vs
Side-by-side financial comparison of LXP Industrial Trust (LXP) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
LXP Industrial Trust is the larger business by last-quarter revenue ($86.7M vs $57.2M, roughly 1.5× Vanda Pharmaceuticals Inc.). LXP Industrial Trust runs the higher net margin — 33.2% vs -246.8%, a 279.9% gap on every dollar of revenue. On growth, Vanda Pharmaceuticals Inc. posted the faster year-over-year revenue change (7.6% vs -14.0%). Over the past eight quarters, Vanda Pharmaceuticals Inc.'s revenue compounded faster (9.8% CAGR vs 0.3%).
LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
LXP vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.7M | $57.2M |
| Net Profit | $28.8M | $-141.2M |
| Gross Margin | 81.5% | — |
| Operating Margin | 34.6% | -70.5% |
| Net Margin | 33.2% | -246.8% |
| Revenue YoY | -14.0% | 7.6% |
| Net Profit YoY | — | -2774.3% |
| EPS (diluted) | — | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.7M | $57.2M | ||
| Q3 25 | $86.9M | $56.3M | ||
| Q2 25 | $87.7M | $52.6M | ||
| Q1 25 | $88.9M | $50.0M | ||
| Q4 24 | $100.9M | $53.2M | ||
| Q3 24 | $85.6M | $47.7M | ||
| Q2 24 | $85.8M | $50.5M | ||
| Q1 24 | $86.3M | $47.5M |
| Q4 25 | $28.8M | $-141.2M | ||
| Q3 25 | $36.3M | $-22.6M | ||
| Q2 25 | $29.1M | $-27.2M | ||
| Q1 25 | $19.0M | $-29.5M | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | $6.3M | $-5.3M | ||
| Q2 24 | $5.4M | $-4.5M | ||
| Q1 24 | $-269.0K | $-4.1M |
| Q4 25 | 81.5% | — | ||
| Q3 25 | 82.3% | — | ||
| Q2 25 | 81.9% | — | ||
| Q1 25 | 80.7% | — | ||
| Q4 24 | 85.3% | — | ||
| Q3 24 | 82.5% | — | ||
| Q2 24 | 82.0% | — | ||
| Q1 24 | 82.4% | — |
| Q4 25 | 34.6% | -70.5% | ||
| Q3 25 | 50.4% | -55.6% | ||
| Q2 25 | 33.7% | -73.2% | ||
| Q1 25 | 21.8% | -82.0% | ||
| Q4 24 | — | -19.3% | ||
| Q3 24 | 7.9% | -23.1% | ||
| Q2 24 | 6.9% | -20.1% | ||
| Q1 24 | 1.0% | -19.5% |
| Q4 25 | 33.2% | -246.8% | ||
| Q3 25 | 41.7% | -40.1% | ||
| Q2 25 | 33.2% | -51.7% | ||
| Q1 25 | 21.4% | -58.9% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | 7.4% | -11.2% | ||
| Q2 24 | 6.3% | -9.0% | ||
| Q1 24 | -0.3% | -8.7% |
| Q4 25 | — | $-2.40 | ||
| Q3 25 | $0.12 | $-0.38 | ||
| Q2 25 | $0.09 | $-0.46 | ||
| Q1 25 | $0.06 | $-0.50 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | $0.02 | $-0.09 | ||
| Q2 24 | $0.01 | $-0.08 | ||
| Q1 24 | $-0.01 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $170.4M | $84.9M |
| Total DebtLower is stronger | $1.4B | — |
| Stockholders' EquityBook value | $2.0B | $327.2M |
| Total Assets | $3.5B | $488.9M |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $170.4M | $84.9M | ||
| Q3 25 | $229.7M | $70.0M | ||
| Q2 25 | $71.0M | $81.0M | ||
| Q1 25 | $70.9M | $111.8M | ||
| Q4 24 | $101.8M | $102.3M | ||
| Q3 24 | $55.0M | $100.5M | ||
| Q2 24 | $48.7M | $103.0M | ||
| Q1 24 | $293.8M | $125.2M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.0B | $327.2M | ||
| Q3 25 | $2.1B | $466.0M | ||
| Q2 25 | $2.1B | $486.3M | ||
| Q1 25 | $2.1B | $511.4M | ||
| Q4 24 | $2.1B | $538.5M | ||
| Q3 24 | $2.1B | $541.2M | ||
| Q2 24 | $2.1B | $542.5M | ||
| Q1 24 | $2.2B | $544.0M |
| Q4 25 | $3.5B | $488.9M | ||
| Q3 25 | $3.7B | $601.1M | ||
| Q2 25 | $3.7B | $624.7M | ||
| Q1 25 | $3.8B | $631.9M | ||
| Q4 24 | $3.8B | $656.2M | ||
| Q3 24 | $3.9B | $645.1M | ||
| Q2 24 | $3.9B | $651.4M | ||
| Q1 24 | $4.2B | $652.7M |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.73× | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $188.7M | $-29.4M |
| Free Cash FlowOCF − Capex | — | $-29.5M |
| FCF MarginFCF / Revenue | — | -51.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | 6.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $188.7M | $-29.4M | ||
| Q3 25 | $63.5M | $-31.6M | ||
| Q2 25 | $44.3M | $-15.3M | ||
| Q1 25 | $39.0M | $-33.1M | ||
| Q4 24 | $211.2M | $-1.8M | ||
| Q3 24 | $64.6M | $-14.6M | ||
| Q2 24 | $38.5M | $-6.9M | ||
| Q1 24 | $38.9M | $7.6M |
| Q4 25 | — | $-29.5M | ||
| Q3 25 | — | $-31.8M | ||
| Q2 25 | — | $-15.6M | ||
| Q1 25 | — | $-33.6M | ||
| Q4 24 | — | $-2.0M | ||
| Q3 24 | — | $-14.7M | ||
| Q2 24 | — | $-7.0M | ||
| Q1 24 | — | $7.6M |
| Q4 25 | — | -51.6% | ||
| Q3 25 | — | -56.5% | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | -67.1% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | — | -30.9% | ||
| Q2 24 | — | -13.9% | ||
| Q1 24 | — | 15.9% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 6.56× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 2.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.18× | — | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LXP
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
